(Q36982448)

17 August 2017

1 reference

title

Survivin: a promising biomarker for detection and prognosis of bladder cancer (English)

1 reference

17 August 2017

0 references

2

Yair Lotan

1 reference

17 August 2017

3

Shahrokh F Shariat

1 reference

17 August 2017

Vitaly Margulis

1

1 reference

17 August 2017

26 October 2007

1 reference

17 August 2017

World Journal of Urology

1 reference

17 August 2017

26

1 reference

17 August 2017

59-65

1 reference

17 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s00345-007-0219-y

17 August 2017

0 references

cites work

Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer

1 reference

12 December 2020

Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy

1 reference

12 December 2020

Survivin study: an update of "what is the next wave"?

1 reference

12 December 2020

The survivin-like C. elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone

1 reference

12 December 2020

Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer

1 reference

12 December 2020

Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients

1 reference

12 December 2020

Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder.

1 reference

12 December 2020

Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm

1 reference

12 December 2020

Survivin splice variants regulate the balance between proliferation and cell death

1 reference

12 December 2020

Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome

1 reference

12 December 2020

Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer

1 reference

12 December 2020

Antisense RNA of survivin gene enhances the taxol-induced apoptosis and sensitivity to chemotherapy drugs in bladder cancer cells: an in vitro experiment

1 reference

12 December 2020

IAP family proteins--suppressors of apoptosis

1 reference

12 December 2020

siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth

1 reference

12 December 2020

Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.

1 reference

12 December 2020

Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer

1 reference

12 December 2020

Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas.

1 reference

12 December 2020

Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer

1 reference

12 December 2020

Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.

1 reference

12 December 2020

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

12 December 2020

Comparison of cytology and nuclear matrix protein 22 (NMP 22) for the detection and follow-up of bladder-cancer.

1 reference

12 December 2020

Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis

1 reference

12 December 2020

Urine detection of survivin and diagnosis of bladder cancer

1 reference

12 December 2020

Survivin expression is associated with bladder cancer presence, stage, progression, and mortality

1 reference

12 December 2020

Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?

1 reference

12 December 2020

Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer

1 reference

12 December 2020

Survivin: a promising tumor biomarker

1 reference

12 December 2020

Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder Cancer

1 reference

12 December 2020

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder

1 reference

12 December 2020

Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis

1 reference

12 December 2020

The health economics of bladder cancer: a comprehensive review of the published literature.

1 reference

12 December 2020

Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium

1 reference

12 December 2020

Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA.

1 reference

12 December 2020

Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.

1 reference

12 December 2020

Apoptosis in the development and treatment of cancer

1 reference

12 December 2020

The expression and significance of survivin mRNA in urinary bladder carcinomas.

1 reference

12 December 2020

Regulation of microtubule stability and mitotic progression by survivin.

1 reference

12 December 2020

Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma.

1 reference

12 December 2020

Cancer statistics, 2007

1 reference

12 December 2020

Detection of newly diagnosed bladder cancer, bladder cancer recurrence and bladder cancer in patients with hematuria using quantitative rt-PCR of urinary survivin.

1 reference

12 December 2020

Regulation of mitochondrial Smac/DIABLO-selective release by survivin

1 reference

12 December 2020

Validating survivin as a cancer therapeutic target

1 reference

12 December 2020

10.1007/S00345-007-0219-Y

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17962949